← Leaderboards
Sandra W Ryeom
Columbia University Health Sciences
$6,449,433
Attributed
$11,208,185
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,208,185 · 10
By mechanism
R01$9,919,360 · 4
T32$579,128 · 1
P50$370,216 · 1
P30$178,374 · 2
R56$121,875 · 1
F32$39,232 · 1
Top collaborators
- Silas Maniatis8 shared
- Karol Piotr Nowicki-Osuch8 shared
- Julian Abrams2 shared
- Nabeel Bardeesy2 shared
- Karen R Rabin2 shared
- Anil K Rustgi2 shared
- William R Sellers2 shared
- Cynthia J. Guidos1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Timothy Cragin Wang$52,188,834
- Silas Maniatis$1,360,019
- Karol Piotr Nowicki-Osuch$1,360,019
- Mingyao Li$17,764,335
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMalignant NeoplasmsSignal TransductionMouse ModelMediatingPathway InteractionsEndothelial CellsInsightPreventMolecularCellsAngiogenesisTissuesGeneticIn VitroEngineeringProgramsPlayFundingMemberAngiogenic FactorPublishingCalcineurinOrgan
Grant awards (39)
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer$898,099
R01 · FY2025 · CA · contact PI
Targeting FGFR Alterations in Gastroesophageal Cancer$680,532
R01 · FY2025 · CA · contact PI
Preventing Fatal Infections in Children with Down Syndrome During Treatment for Acute Lymphoblastic Leukemia$533,887
R01 · FY2025 · CA · contact PI
Multidisciplinary Training in Gastrointestinal Cancers$385,984
T32 · FY2025 · CA
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer$98,559
R01 · FY2025 · CA · contact PI
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer$59,881
R01 · FY2025 · CA · contact PI
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer$1,073,015
R01 · FY2024 · CA · contact PI
Targeting FGFR Alterations in Gastroesophageal Cancer$716,314
R01 · FY2024 · CA · contact PI
Preventing Fatal Infections in Children with Down Syndrome During Treatment for Acute Lymphoblastic Leukemia$548,211
R01 · FY2024 · CA · contact PI
Multidisciplinary Training in Gastrointestinal Cancers$193,144
T32 · FY2024 · CA
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer$67,328
R01 · FY2024 · CA · contact PI
Elucidating the mechanisms by which the extracellular matrix contribute to gastroesophageal cancer pathobiology$15,925
R01 · FY2024 · CA · contact PI
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer$908,985
R01 · FY2023 · CA · contact PI
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer$958,264
R01 · FY2022 · CA · contact PI
Project 4 - Characterizing and Overcoming Resistance to ERBB2 Directed Therapy in Metastatic Gastric and Esophageal Adenocarcinoma$370,216
P50 · FY2022 · CA · contact PI
The role of endothelial cells in the formation of early metastatic niches in the lung$104,959
R56 · FY2021 · CA · contact PI
Tumor Biology Program$83,107
P30 · FY2021 · CA · contact PI
The role of endothelial cells in the formation of early metastatic niches in the lung$16,916
R56 · FY2021 · CA · contact PI
Tumor Biology Research Program$38,760
P30 · FY2020 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$331,739
R01 · FY2019 · CA · contact PI
Tumor Biology Research Program$38,794
P30 · FY2019 · CA · contact PI
Tumor Biology Research Program$7,212
P30 · FY2019 · CA · contact PI
Tumor Biology Research Program$5,768
P30 · FY2019 · CA · contact PI
Tumor Biology Research Program$3,627
P30 · FY2019 · CA · contact PI
Tumor Biology Research Program$1,106
P30 · FY2019 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$342,000
R01 · FY2018 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$69,420
R01 · FY2018 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$342,000
R01 · FY2017 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$69,420
R01 · FY2017 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$342,000
R01 · FY2016 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$52,451
R01 · FY2016 · CA · contact PI
Calcineurin-NFAT regulates endothelial activation in pre-metastatic sites$342,000
R01 · FY2015 · CA · contact PI
Negative Regulation of VEGF-Mediated Angiogenesis$272,447
R01 · FY2013 · CA · contact PI
Negative Regulation of VEGF-Mediated Angiogenesis$289,837
R01 · FY2012 · CA · contact PI
Negative Regulation of VEGF-Mediated Angiogenesis$289,837
R01 · FY2011 · CA · contact PI
Negative Regulation of VEGF-Mediated Angiogenesis$298,800
R01 · FY2010 · CA · contact PI
Negative Regulation of VEGF-Mediated Angiogenesis$296,933
R01 · FY2009 · CA · contact PI
Negative Regulation of VEGF-Mediated Angiogenesis$21,476
R01 · FY2009 · CA · contact PI
Z0 1 SIGNALING IN CORNEAL EPITHELIAL CELL BIOLOGY$39,232
F32 · FY2000 · EY